Editorial
Ototoxicity: a worrying problem for survivors of high-risk neuroblastoma
Translational Cancer Research
2014;
3
(6)
:521-524
.
(04 December 2014)
Original Article
Bilateral Gamma Knife thalamotomy for treatment of axial tremor
Translational Cancer Research
2014;
3
(6)
:525-529
.
(04 December 2014)
Intraoperative Radiotherapy1
Evidence behind use of orthovolt intraoperative radiotherapy and other techniques of IORT in recurrent colorectal cancer treatment
Translational Cancer Research
2014;
3
(6)
:530-536
.
(04 December 2014)
Intraoperative radiotherapy in the treatment of gastrointestinal malignancies
Translational Cancer Research
2014;
3
(6)
:537-540
.
(04 December 2014)
Breast Cancer2
Should trastuzumab be administered concomitantly with anthracycline in women with early, HER2-positive breast cancer?
Translational Cancer Research
2014;
3
(6)
:541-546
.
(04 December 2014)
Neoadjuvant chemotherapy: what does it take to tAnGo?
Translational Cancer Research
2014;
3
(6)
:547-551
.
(04 December 2014)
Beyond convention in treatment of metastatic breast cancer—rediscover overall survival
Translational Cancer Research
2014;
3
(6)
:552-554
.
(04 December 2014)
Renal Cell Carcinoma3
Axitinib as first-line therapy in metastatic renal cell carcinoma
Translational Cancer Research
2014;
3
(6)
:555-557
.
(04 December 2014)
Axitinib for the first line therapy of renal cancer: failure of a trial or failure of a strategy?
Translational Cancer Research
2014;
3
(6)
:558-561
.
(04 December 2014)
Axitinib in renal cell carcinoma: now what do we do?
Translational Cancer Research
2014;
3
(6)
:562-566
.
(04 December 2014)
Commentary
A second opportunity to come for anti-angiogenics in prostate cancer?
Translational Cancer Research
2014;
3
(6)
:567-570
.
(04 December 2014)
Meet the Professor4
Prof. Won Seog Kim: current and future treatment for malignant lymphoma
Translational Cancer Research
2014;
3
(6)
:571-572
.
(04 December 2014)
Disclosure:
1. The series “Intraoperative Radiotherapy” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Frederik Wenz and Elena Sperk served as the unpaid Guest Editors for the series.
2. The series “Breast Cancer” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding.
3. The series “Renal Cell Carcinoma” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding.
4. The series “Meet the Professor” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding.